Rochester Drug Co-Operative will no longer sell controlled pharmaceuticals

Business

ROCHESTER, N.Y. (WROC) — Rochester Drug Co-Operative, a local healthcare production company, announced Tuesday that it would no longer sell controlled pharmaceuticals.

Last April, two former company executives of the company faced federal charges and agreed to pay $20 million as part of a case brought by the federal government over its failure to report suspicious opioid drug orders from pharmacies.

Along with the $20 million fine over a five-year period, the company admitted to the failures and agreed to three years of independent compliance monitoring.

Tuesday, company officials said the specific drugs they will no longer sell represent a “relatively small percent of total sales,” they account for significant legal and compliance expenses.

“The ever-increasing expenses associated with the legal and regulatory compliance for this segment of drugs are simply not sustainable,” company officials said in a statement. We are grateful for the loyalty and patience our customers have shown as we have worked through this decision.”

Copyright 2020 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Trending Stories

Don't Miss

More Don't Miss